Vermillion Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175K Sell
1,359
-140
-9% -$16.4K 0.04% 267
2026
Q1
$180K Buy
1,499
+149
+11% +$17.2K 0.07% 101
2025
Q4
$142K Sell
1,350
-11
-0.8% -$1.03K 0.06% 116
2025
Q3
$114K Hold
1,361
0.03% 336
2025
Q2
$108K Buy
1,361
+153
+13% +$12.2K 0.05% 122
2025
Q1
$108K Hold
1,208
0.03% 303
2024
Q4
$120K Buy
+1,208
New +$125K 0.06% 116

Other funds holding MRK

Vermillion Wealth Management's MRK Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Merck (MRK) stake by 9.3% in Q2 2026, selling an estimated $16.4K and leaving 1,359 shares worth $175K. The position accounts for 0.04% of the portfolio, ranked #267.

Vermillion Wealth Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $180K in Q1 2026. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vermillion Wealth Management held 1,359 shares of Merck worth $175K as of Q2 2026.
  • Vermillion Wealth Management sold 140 Merck shares in Q2 2026, an estimated $16.4K.
  • Merck made up 0.04% of Vermillion Wealth Management's portfolio in Q2 2026, its #267 holding.
  • Vermillion Wealth Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Merck position peaked at $180K in Q1 2026.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.